What is Citigroup's price target for LUNG?

Citigroup's latest stated price target for Pulmonx Corporation (LUNG) is $7.50, from its action on Dec 11, 2024.

What is Citigroup's rating on LUNG?

Citigroup rates LUNG Neutral, a neutral rating, as of Dec 11, 2024.

When did Citigroup last change its view on LUNG?

On Dec 11, 2024, Citigroup downgrades to Neutral from Buy, price target $17 to $7.50.

Citigroup LUNG price target and rating history

Pulmonx Corporation (LUNG) · Health Care

Citigroup rates Pulmonx Corporation (LUNG) Neutral with a $7.50 price target, as of its latest action on Dec 11, 2024. It has published 3 rating actions on LUNG since July 2022, including 1 upgrade and 2 downgrades.

Current rating: Neutral
Price target: $7.50
Median target, all firms: Too few
Actions on LUNG: 3

Citigroup price target on LUNG

Citigroup price target on LUNG, each point a stated target, July 2022 to December 2024.

Every Citigroup rating on LUNG

Dec 11, 2024
DowngradeCitigroup downgrades to Neutral from Buy, price target $17 to $7.50
Dec 12, 2022
UpgradeCitigroup upgrades to Buy from Neutral, price target $14 to $10
Jul 11, 2022
DowngradeCitigroup downgrades to Neutral from Buy, price target $23 to $19

Questions about Citigroup and LUNG

What is Citigroup's price target for LUNG?: Citigroup's latest stated price target for Pulmonx Corporation (LUNG) is $7.50, from its action on Dec 11, 2024.
What is Citigroup's rating on LUNG?: Citigroup rates LUNG Neutral, a neutral rating, as of Dec 11, 2024.
When did Citigroup last change its view on LUNG?: On Dec 11, 2024, Citigroup downgrades to Neutral from Buy, price target $17 to $7.50.

More LUNG rating histories

Wells Fargo4

All Citigroup ratings LUNG news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.